Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm as Vice President, Preclinical Development. Nikole joins the team with an expansive preclinical background serving the pharmaceutical industry and Clinical Research organizations (CRO) and is based out of Alira Health’s headquarters in Framingham, Massachusetts.
“It is an honor to have Nikole join Alira Health’s Product Development team to accelerate our business development efforts and manage our preclinical offerings, “ said Dr. Mitchell Sanders, Chief Scientific Officer. “Nikole’s wealth of experience in preclinical models, operations, and project management helps us expand our preclinical lab services in oncology, liver and metabolic disease, wound care, and surgery.
“I am excited to join the Alira Health team of dedicated professionals who work tirelessly to improve the healthcare industry and patient care,” said Nikole. “I look forward to working alongside our clients, developing, and improving technologies in the pre-clinical space, and further advancing patient care around the globe.”
Nikole brings over 20 years of preclinical experience in the CRO and pharmaceutical spaces. She is an experienced Vice President of Operations with a proven history of working in both large and small organizations.
Prior to Alira Health, Nikole worked with Woodland Pharmaceuticals LLC and has experience in oncology, NASH and metabolic diseases, PK/PD, Good Laboratory Practice (GLP), Data QC, and business development. She currently serves as a voting member of the Tufts University and Tufts Medical Center Institutional Animal Care and Use Committee.
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
7e Journée start-up innovantes du dispositif médical
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
Data Intelligence for Opportunity Screening and Prioritization in Drug Discovery
Event: Innovations In Wound Healing Annual Conference
Event: SAWC Fall 2021
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Subscribe to our newsletter for the latest news, events, and thought leadership